Allergan is recalling one lot of birth-control pills — or 170,000 packs — because the first four pills in each 28-pill pack are inactive, placing women at risk of pregnancy.

One lot of Taytulla physician sample packs (marked lot #5620706 Exp. May 2019) contained the out-of-order pills, the company said. It learned about the error from a doctor who reported it.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • In the current hyper-partisan environment, I can only suggest that Allergan needs to find if it has “a hardened Republican in QA” who also opposes the concept of birth control. That would explain, “this little mix-up.”

    Justify, absolutely not but it’s a nifty conspiracy theory……

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy